Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism

Genes and Immunity

Volumn 3, Issue 7, 2002, Pages 436-439

  Van Der Pouw Kraan, Tineke C T M ^a,e   Kucukaycan M ^b   Bakker, A M ^c   Baggen, J M C ^a   Van Der Zee, J S ^d   Dentener, M A ^b   Wouters, E F M ^b   Verweij, C L ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

COPD; Genetics; Human; IL 13; Immunology; Polymorphism

Indexed keywords

INTERLEUKIN 13;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-13; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 2442434976     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6363896     Document Type: Article

References (28)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.
2. Balzano G, Stefanelli F, Iorio C et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999; 160: 1486-1492.
3. O'Byrne PM, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med 1999; 159: 41-S63
4. Sluiter HJ, Koeter GH, deMonchy JG et al. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991; 4: 479-489.
5. Tashkin DP, Altose MD, Connett JE et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996; 153: 1802-1811.
6. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356: 1313-1317.
7. Hospers JJ, Schouten JP, Weiss ST, Rijcken B, Postma DS. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. Am J Respir Crit Care Med 1999; 160: 1869-1874.
8. Postma DS, Bleecker ER, Amelung PJ et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
9. Doull IJM, Lawrence S, Watson M et al. Allelic association of gene markers on chromosome 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996; 153: 1280-1284.
10. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152-1156.
11. A genome-wide search for asthma susceptibility loci in ethnically diverse populations: The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997; 15: 389-392.
12. Hilton DJ, Zhang J, Metcalf D et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Nat Acad Sci 1996; 93: 497-501.
13. Grunig W, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263.
14. Wills-Karp M, Luyimbazi j, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
15. Zheng T, Zhu Z, Wang Z et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106: 1081-1093.
16. van der Pouw Kraan TC, van Veen A, Boeije LC et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999; 1: 61-65.
17. van der Pouw Kraan TC, Aarden LA, Verweij K et al. Polymorphism in the IL-13 promoter. Science 1999; 286: 1647b
18. Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105: 506-513.
19. Liu X, Nickel R, Beyer K et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS- 90). J Allergy Clin Immunol 2000; 106: 167-170.
20. Heinzmann A, Mao XQ, Akaiwa M et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9: 549-559.
21. Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25 (Suppl. 2): 74-78.
22. Suzuki I, Yamaguchi E, Hizawa N, Itoh A, Kawakami Y. A new polymorphism in the 5′ flanking region of the human interleukin (IL)-4 gene. Immunogenetics 1999; 49: 738-739.
23. Suzuki I, Hizawa N, Yamaguchi E, Kawakami Y Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels. Clin Exp Allergy 2000; 30: 1746-1749.
24. American Thoracic Society. Medical section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
25. Cohn L, Homer RJ, MacLeod H et al. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol 1999; 162: 6178-6183.
26. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998; 8: 339-342.
27. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153: 1530-1535.
28. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333-1338.